ExploreWatchlistsPricing
  1. JP-listed companies
  2. Mochida Pharmaceutical Co.,Ltd.
  3. Financials
  4. Gross margin (%)

Mochida Pharmaceutical Co.,Ltd. (4534)

Market cap
¥122.5B
P/E ratio
14.2x
A Japanese pharmaceutical company that develops and sells prescription drugs and healthcare products through a network of manufacturing and sales subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndGross margin (%) YoY (%)
Mar 31, 202551.1+1.06%
Mar 31, 202450.6-5.18%
Mar 31, 202353.4-1.25%
Mar 31, 202254.1+1.60%
Mar 31, 202153.2+4.31%
Mar 31, 202051+3.23%
Mar 31, 201949.4-1.56%
Mar 31, 201850.2-13.23%
Mar 31, 201757.8-2.96%
Mar 31, 201659.6-2.50%
Mar 31, 201561.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat